• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

离子载体对血管性血友病和先天性无纤维蛋白原血症中血小板聚集的影响。与瑞斯托菌素的比较。

The effect of ionophore on platelet aggregation in von Willebrand's disease and in congenital afibrinogenemia. A comparison with ristocetin.

作者信息

Girolami A, Fabris F, Marco L, Peruffo R

出版信息

Acta Haematol. 1976;56(3):151-9. doi: 10.1159/000207932.

DOI:10.1159/000207932
PMID:826070
Abstract

Platelet aggregation in citrated and heparinized plasma by ionophore A 23187 and Ristocetin was studied in normal subjects and in patients with von Willebrand's disease and congenital afibrinogenemia. Aggregation by ionophore was normal in all groups both in citrated and heparinized plasma. Aggregation by Ristocetin in citrated plasma was normal in congenital afibrinogenemia, in normal subjects and in types II and III of von Willebrand's disease. It was absent in classical von Willebrand's disease, type I. In heparinized plasma it was absent in all groups, except in some patients with von Willebrand's disease, type III. It is concluded that ionophore A 23187 behaves in a different way than Ristocetin and has no diagnostic implications.

摘要

在正常受试者以及患有血管性血友病和先天性无纤维蛋白原血症的患者中,研究了离子载体A 23187和瑞斯托菌素在枸橼酸盐血浆和肝素化血浆中的血小板聚集情况。在枸橼酸盐血浆和肝素化血浆中,所有组中离子载体诱导的聚集均正常。在先天性无纤维蛋白原血症、正常受试者以及血管性血友病II型和III型中,瑞斯托菌素在枸橼酸盐血浆中诱导的聚集正常。在经典的血管性血友病I型中,该聚集不存在。在肝素化血浆中,除了一些血管性血友病III型患者外,所有组中该聚集均不存在。结论是,离子载体A 23187的行为方式与瑞斯托菌素不同,且无诊断意义。

相似文献

1
The effect of ionophore on platelet aggregation in von Willebrand's disease and in congenital afibrinogenemia. A comparison with ristocetin.离子载体对血管性血友病和先天性无纤维蛋白原血症中血小板聚集的影响。与瑞斯托菌素的比较。
Acta Haematol. 1976;56(3):151-9. doi: 10.1159/000207932.
2
The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects.肝素对因因子VIII或纤维蛋白原缺陷所致先天性出血性疾病中常见诱导剂及瑞斯托霉素诱导的血小板聚集的影响。
Blut. 1975 Oct;31(4):219-26. doi: 10.1007/BF01633505.
3
Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.血管性血友病中瑞斯托霉素诱导的血小板聚集缺陷及其通过因子VIII的纠正。
J Clin Invest. 1973 Nov;52(11):2697-707. doi: 10.1172/JCI107464.
4
Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.与瑞斯托霉素诱导的血小板聚集相关的血小板膜糖蛋白。对伯纳德-苏利耶综合征和血管性血友病患者血小板上蛋白质的研究。
J Clin Invest. 1976 Jan;57(1):112-24. doi: 10.1172/JCI108251.
5
Studies on the pathophysiology and treatment of von Willebrand's disease. IV. Mechanism of increased ristocetin-induced platelet aggregation in von Willebrand's disease.血管性血友病的病理生理学与治疗研究。IV. 血管性血友病中瑞斯托霉素诱导的血小板聚集增加的机制。
Thromb Res. 1980 Sep 15;19(6):857-67. doi: 10.1016/0049-3848(80)90013-4.
6
Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.正常受试者及血管性血友病患者血小板结合的瑞斯托菌素聚集因子
J Lab Clin Med. 1976 Jun;87(6):976-86.
7
Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.瑞斯托霉素-血管性血友病因子检测及瑞斯托霉素诱导的血小板聚集评估。
Am J Clin Pathol. 1975 Feb;63(2):210-8. doi: 10.1093/ajcp/63.2.210.
8
Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.瑞斯托霉素在血管性血友病诊断中的应用:瑞斯托霉素诱导聚集率和聚集百分比与瑞斯托霉素诱导聚集所需血浆因子水平的比较。
Thromb Diath Haemorrh. 1975 Nov 15;34(2):465-74.
9
Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.血管性血友病中因子VIII(活性与抗原)及瑞斯托霉素诱导的血小板聚集之间的解离
Acta Haematol. 1975;53(1):44-8. doi: 10.1159/000208154.
10
The von Willebrand syndrome.
Br J Haematol. 1975 Apr;29(4):605-16. doi: 10.1111/j.1365-2141.1975.tb02747.x.